LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,418,645 | -15.4% | 157,187 | +1.8% | 0.00% | 0.0% |
| Q2 2023 | $11,134,114 | +2.9% | 154,426 | +5.0% | 0.00% | 0.0% |
| Q1 2023 | $10,823,104 | -3.9% | 147,133 | -12.7% | 0.00% | -25.0% |
| Q4 2022 | $11,264,217 | -18.5% | 168,626 | +5.0% | 0.00% | -20.0% |
| Q3 2022 | $13,828,000 | -2.6% | 160,577 | +1.0% | 0.01% | 0.0% |
| Q2 2022 | $14,192,000 | -18.3% | 159,064 | +3.0% | 0.01% | 0.0% |
| Q1 2022 | $17,378,000 | -26.6% | 154,481 | +0.8% | 0.01% | -28.6% |
| Q4 2021 | $23,666,000 | +18.2% | 153,213 | +6.6% | 0.01% | 0.0% |
| Q3 2021 | $20,028,000 | +11.3% | 143,758 | +4.8% | 0.01% | +16.7% |
| Q2 2021 | $17,996,000 | -8.9% | 137,173 | +5.9% | 0.01% | -14.3% |
| Q1 2021 | $19,747,000 | +64.0% | 129,526 | +7.0% | 0.01% | +40.0% |
| Q4 2020 | $12,044,000 | +5.0% | 121,105 | +0.7% | 0.01% | 0.0% |
| Q3 2020 | $11,469,000 | -0.5% | 120,312 | +16.7% | 0.01% | -16.7% |
| Q2 2020 | $11,532,000 | +52.4% | 103,096 | -0.9% | 0.01% | +50.0% |
| Q1 2020 | $7,569,000 | -34.0% | 104,081 | -5.3% | 0.00% | -33.3% |
| Q4 2019 | $11,468,000 | -18.0% | 109,956 | -21.7% | 0.01% | -25.0% |
| Q3 2019 | $13,980,000 | -31.6% | 140,442 | -21.6% | 0.01% | -33.3% |
| Q2 2019 | $20,451,000 | -18.7% | 179,154 | -10.5% | 0.01% | -25.0% |
| Q1 2019 | $25,167,000 | +1.3% | 200,191 | +9.4% | 0.02% | -15.8% |
| Q4 2018 | $24,834,000 | -47.6% | 183,002 | +5.9% | 0.02% | -40.6% |
| Q3 2018 | $47,438,000 | +68.5% | 172,822 | +27.2% | 0.03% | +52.4% |
| Q2 2018 | $28,149,000 | +26.9% | 135,871 | +1.2% | 0.02% | +23.5% |
| Q1 2018 | $22,184,000 | +23.9% | 134,313 | +2.7% | 0.02% | +21.4% |
| Q4 2017 | $17,903,000 | +2.9% | 130,742 | +2.3% | 0.01% | -6.7% |
| Q3 2017 | $17,399,000 | +29.4% | 127,792 | +15.4% | 0.02% | +15.4% |
| Q2 2017 | $13,442,000 | +23.3% | 110,721 | +7.5% | 0.01% | +18.2% |
| Q1 2017 | $10,898,000 | +24.6% | 102,959 | +19.6% | 0.01% | +10.0% |
| Q4 2016 | $8,745,000 | +4.3% | 86,060 | +4.8% | 0.01% | 0.0% |
| Q3 2016 | $8,385,000 | -10.9% | 82,152 | +4.2% | 0.01% | -16.7% |
| Q2 2016 | $9,407,000 | +12.6% | 78,866 | +1.1% | 0.01% | +9.1% |
| Q1 2016 | $8,358,000 | -28.9% | 78,043 | -28.0% | 0.01% | -31.2% |
| Q4 2015 | $11,753,000 | +13.1% | 108,401 | -10.6% | 0.02% | +6.7% |
| Q3 2015 | $10,388,000 | -12.5% | 121,275 | +3.0% | 0.02% | -6.2% |
| Q2 2015 | $11,876,000 | -34.2% | 117,700 | -49.7% | 0.02% | -36.0% |
| Q1 2015 | $18,043,000 | +54.3% | 233,982 | +6.4% | 0.02% | +38.9% |
| Q4 2014 | $11,697,000 | +61.9% | 219,816 | +43.0% | 0.02% | +50.0% |
| Q3 2014 | $7,226,000 | +30.2% | 153,762 | +72.5% | 0.01% | +33.3% |
| Q2 2014 | $5,552,000 | +56.2% | 89,122 | +68.7% | 0.01% | +50.0% |
| Q1 2014 | $3,554,000 | +34.0% | 52,832 | +4.8% | 0.01% | +20.0% |
| Q4 2013 | $2,652,000 | +20.4% | 50,402 | +4.1% | 0.01% | +25.0% |
| Q3 2013 | $2,202,000 | +18.1% | 48,412 | +3.6% | 0.00% | 0.0% |
| Q2 2013 | $1,865,000 | – | 46,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |